US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: Unpacking a 111% Upside Potential in the Healthcare Sector

Enovis Corporation (NYSE: ENOV) is catching the eye of investors with its promising potential upside and strategic positioning in the healthcare sector. Operating primarily in the..

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 106% Upside Potential in the Healthcare Sector

Astrana Health Inc. (ASTH), a prominent player in the healthcare management industry, is drawing significant attention from investors with its compelling potential upside of 106.68%. Headquartered..

Metsera, Inc. (MTSR) Stock Analysis: A Promising 66% Upside in the Healthcare Biotech Sector

Metsera, Inc. (MTSR), a burgeoning player in the healthcare biotechnology sector, has caught the attention of investors with its innovative approach to tackling obesity and related..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Is There a 116% Upside Potential for This Healthcare Innovator?

LifeStance Health Group, Inc. (LFST), a significant player in the healthcare sector, is gaining attention from investors with a remarkable potential upside of 116.35%. As a..

IDEAYA Biosciences, Inc. (IDYA): Analyst Consensus Points to 86% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of the precision medicine oncology sector, offering compelling prospects for investors looking to capitalize on the biotechnology..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Harnessing Biotech Potential with a 168% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands as a noteworthy entity in the biotechnology sector, offering substantial promise through its innovative therapeutic antibody developments aimed at addressing..

UFP Technologies, Inc. (UFPT) Investor Outlook: Exploring a Potential 37.45% Upside

UFP Technologies, Inc. (UFPT) stands out in the healthcare sector, particularly within the medical devices industry, as it continues to innovate in the creation of specialized..

Vericel Corporation (VCEL) Stock Analysis: Evaluating a Promising 43% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is capturing investor attention with its strong foothold in the biopharmaceutical sector, particularly in the niche markets of sports medicine and severe..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 30.92% Potential Upside

Investors interested in the healthcare sector’s digital transformation have likely heard of Teladoc Health, Inc. (TDOC), a pioneer in virtual healthcare services. Despite its recent challenges,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Biotech Innovator Poised for 84% Potential Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a cutting-edge player in the biotechnology sector, is making waves with its innovative approach to treating severe allergic reactions. Headquartered in..

CONMED Corporation (CNMD) Stock Analysis: Evaluating the 14% Potential Upside Amid Healthcare Growth

For those with a keen eye on the healthcare sector, CONMED Corporation (NASDAQ: CNMD) presents a compelling case worth attention. As a key player in the..

Travere Therapeutics (TVTX): Analyst Consensus Highlights a Potential 114% Upside for Investors

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on addressing rare kidney and metabolic diseases, has garnered significant attention from investors, spurred by a compelling..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator with 15% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, specifically in healthcare plans, offers a remarkable investment opportunity for those keen on the burgeoning..

Clover Health Investments (CLOV) Stock Report: Analyzing a 62.76% Potential Upside for Investors

Clover Health Investments, Corp (NASDAQ: CLOV) is capturing the attention of investors with its significant potential upside of 62.76%, as indicated by analyst target prices. Specializing..

Belite Bio, Inc (BLTE) Stock Analysis: Unpacking a 34% Upside with Strong Buy Ratings

Belite Bio, Inc (BLTE) is capturing the attention of investors in the biotechnology sector, driven by its promising drug development pipeline and a robust 34.33% potential..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A 34.91% Potential Upside in Healthcare Investment

Guardian Pharmacy Services, Inc. (GRDN), a pivotal player in the healthcare sector, is making waves in the medical care facilities industry with its innovative technology-enabled services..

Centessa Pharmaceuticals (CNTA) Investor Outlook: Analyzing the 101% Potential Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotechnology sector with its ambitious pipeline and potential for significant growth. Headquartered in Altrincham, UK, Centessa..

ICU Medical, Inc. (ICUI) Stock Analysis: Evaluating a Strong 43% Potential Upside for Investors

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, is renowned for its innovative medical instruments and supplies, particularly in infusion therapy, vascular..

CRISPR Therapeutics AG (CRSP) Investor Outlook: Unpacking the 35.78% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering force in the biotechnology sector, has been captivating investor interest with its revolutionary approach to gene editing. As a..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unlocking a 351.77% Upside Potential in Biotechnology

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor attention with its substantial upside potential in the biotechnology sector. With a market capitalization of $965.47 million, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds